‘Crisis’ and ‘everyday’ initiators: A qualitative study of coercion and agency in the context of methadone maintenance treatment initiation

Drug and Alcohol Review

Volumn 36, Issue 2, 2017, Pages 253-260

  Damon, Will ^a   Small, Will ^a,b   Anderson, Solanna ^a   Maher, Lisa ^c   Wood, Evan ^a,d   Kerr, Thomas ^a,d   McNeil, Ryan ^a,b  

^a BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^b SIMON FRASER UNIVERSITY   (Canada)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

low threshold methadone; methadone maintenance treatment; qualitative research; trauma informed care; treatment retention

Indexed keywords

METHADONE;

ADULT; BRITISH COLUMBIA; COHORT ANALYSIS; FEMALE; HUMAN; INTERVIEW; MALE; MIDDLE AGED; MOTIVATION; OPIATE ADDICTION; OPIATE SUBSTITUTION TREATMENT; PERSUASIVE COMMUNICATION; PROCEDURES; PSYCHOLOGY;

ADULT; BRITISH COLUMBIA; COERCION; COHORT STUDIES; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; METHADONE; MIDDLE AGED; MOTIVATION; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS;

EID: 85015860948     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/dar.12411     Document Type: Article

References (48)

1. Corsi KF, Lehman WK, Booth RE. The effect of methadone maintenance on positive outcomes for opiate injection drug users. J Subst Abuse Treat 2009;37:120–6.
2. MacArthur GJ, Minozzi S, Martin N, et al. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ 2012;345:e5945.
3. Nolan S, Dias Lima V, Fairbairn N, et al. The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users. Addiction 2014;109:2053–9.
4. Maher L, White B, Dore G, et al. Opioid substitution treatment protects against hepatitis C virus acquisition in people who inject drugs: The HITS-c study. Drug Alcohol Depend 2015;146:e191.
5. Oliver P, Keen J, Rowse G, Ewins E, Griffiths L, Mathers N. The effect of time spent in treatment and dropout status on rates of convictions, cautions and imprisonment over 5 years in a primary care-led methadone maintenance service. Addiction 2010;105:732–9.
6. Lawrinson P, Ali R, Buavirat A, et al. Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS. Addiction 2008;103:1484–92.
7. Connock M, Juarez-Garcia A, Jowett S, et al. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technol Assess 2007;11:1–171 iii-iv.
8. Roux P, Carrieri MP, Cohen J, et al. Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment. Clinical Infect Dis 2009;49:1433–40.
9. Uhlmann S, Milloy M-J, Kerr T, et al. Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users. Addiction 2010;105:907–13.
10. Malta M, Strathdee SA, Magnanini MM, Bastos FI. Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review. Addiction 2008;103:1242–57.
11. Wieland WF, Chambers CD. Two methods of utilizing methadone in the outpatient treatment of narcotic addicts. Int J Addict 1970;5:431–8.
12. Dole VP, Nyswander ME. Methadone maintenance: a theoretical perspective. In: Lettieri DJ, Sayers M, Pearson HW, eds. Theories on drug abuse: selected contemporary perspectives. NIDA Research Monograph 30 Washington, DC: U S Government Printing Office 1980; 256–61. Available at: https://archives.drugabuse.gov/pdf/monographs/download30.html (accessed September 2015).
13. Sharif B1, Nosyk B, Sun H, Marsh DC, Anis A. Changes in the characteristics and levels of comorbidity among new patients into methadone maintenance treatment program in British Columbia during its expansion period from 1998–2006. Subst Use Misuse 2014;48:671–82.
14. Reist D. Methadone Maintenance Treatment in British Columbia, 1996–2008: Analysis and Recommendations. Centre for Addictions Research of BC. Available at: http://www.ankors.bc.ca/ccc/CARBC%20First%20methadone%20report-Dan%20Reist.pdf (accessed September 2015), 2010.
15. Ling W1, Hillhouse M, Ang A, Jenkins J, Fahey J. Comparison of behavioral treatment conditions in buprenorphine maintenance. Addiction 2013;108:1788–98.
16. Bourgois P. Disciplining addictions: the bio-politics of methadone and heroin in the United States. Cult Med Psychiatry 2000;24:165–95.
17. Darke S, Sims J, McDonald S, Wickes W. Cognitive impairment among methadone maintenance patients. Addiction 2000;95:687–95.
18. Holt M. Agency and dependency within treatment: drug treatment clients negotiating methadone and antidepressants. Soc Sci Med 2007;64:1937–47.
19. Harris J, McElrath K. Methadone as social control institutionalized stigma and the prospect of recovery. Qual Health Res 2012;22:810–24.
20. Farré M, Mas A, Torrens M, Moreno V, Camí J. Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis. Drug Alcohol Depend 2002;65:283–90.
21. Nosyk B, Marsh DC, Sun H, Schechter MT, Anis AH. Trends in methadone maintenance treatment participation, retention, and compliance to dosing guidelines in British Columbia, Canada: 1996–2006. J Subst Abuse Treat 2010;39:22–31.
22. Fischer B, Rehm J, Kim G, Kirst M. Eyes wide shut?—a conceptual and empirical critique of methadone maintenance treatment. Eur Addict Res 2005;11:1–9.
23. BC Provincial Health Officer. BC opioid substitution treatment system: performance measures: 2013/2014. Available at: http://www2.gov.bc.ca/assets/gov/health/about-bc-s-health-care-system/office-of-the-provincial-health-officer/reports-publications/special-reports/bc-ost-system-measures-2013-2014.pdf (accessed February 2015), 2015.
24. Cao X, Wu Z, Rou K, et al. Retention and its predictors among methadone maintenance treatment clients in China: a six-year cohort study. Drug Alcohol Depend 2014;145:87–93.
25. Kayman DJ, Goldstein MF, Deren S, Rosenblum A. Predicting treatment retention with a brief “Opinions About Methadone” scale. J Psychoactive Drugs 2006;38:93–100.
26. Teesson M, Havard A, Fairbairn S, Ross J, Lynskey M, Darke S. Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking. Drug Alcohol Depend 2005;78:309–15.
27. Fraser S, Valentine K. Substance and substitution: methadone subjects in liberal societies, 1st edn. New York: Palgrave Macmillan, 2008.
28. McNeil R, Kerr T, Anderson S, et al. Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: a qualitative study. Soc Sci Med 2015;133:168–76.
29. Ning AM. Games of truth: rethinking conformity and resistance in narratives of heroin recovery. Med Anthropol 2005;24:349–82.
30. Strike C, Millson M, Hopkins S, Smith C. What is low threshold methadone maintenance treatment? Int J Drug Policy 2013;24:e51–6.
31. College of Physicians & Surgeons of British Columbia. Methadone maintenance program: clinical practice guide. Available at: https://www.cpsbc.ca/files/pdf/MMP-Clinical-Practice-Guideline.pdf (Accessed September 2015), 2014.
32. Parkes T, Reist D. British Columbia methadone maintenance treatment program a qualitative systems review. Victoria: University of Victoria Centre for Addictions Research of BC (April 2010). Accessed at: http://www.ankors.bc.ca/ccc/MMT%20in%20BC%20Qual%20Systems%20Review%20Report%20Summary.pdf (Accessed September 2015).
33. Strathdee SA, Patrick DM, Currie SL, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 1997;11:F59–65.
34. Milloy M-J, Kerr T, Salters K, et al. Incarceration is associated with used syringe lending among active injection drug users with detectable plasma HIV-1 RNA: a longitudinal analysis. BMC Infect Dis 2013;13:565.
35. Corbin J, Strauss A. Basics of qualitative research: techniques and procedures for developing grounded theory, 3rd edn. Thousand Oaks, CA: SAGE Publications, 2014.
36. Radcliffe P, Stevens A. Are drug treatment services only for “thieving junkie scumbags”? Drug users and the management of stigmatised identities. Soc Sci Med 2008;67:1065–73.
37. Keane H. Categorizing methadone: addictions and analgesia. Int J Drug Policy 2013;24:e18–20.
38. Radcliffe P, Stevens A. Are drug treatment services only for “thieving junkie scumbags”? Drug users and the management of stigmatised identities. Soc Sci Med 2008;67:1065–73.
39. Sinoski K, Fowlie J. Methadone users ‘get pharmacy kickbacks’. Vanc Sun. Available at: http://www.canada.com/story.html?id=eb22edd4-ad0a-4fc3-915f-10b4e3a264d2 (accessed September 2015), 2008.
40. Kaltenbach K1, Berghella V, Finnegan L. Opioid dependence during pregnancy: effects and management. Obstet Gynecol Clin North Am 1998;25:139–51.
41. McKenzie M, Zaller N, Dickman SL, et al. A randomized trial of methadone initiation prior to release from incarceration. J Subst Abuse 2012;33:19–29.
42. Najavits LM, Hien D. Helping vulnerable populations: a comprehensive review of the treatment outcome literature on substance use disorder and PTSD. J Clin Psychol 2013;69:433–79.
43. Courtois CA, Ford JD. Treating complex traumatic stress disorders: an evidence-based guide, reprint edn. New York, NY: Guilford Press, 2009.
44. Foa EB. Effective treatments for PTSD: practice guidelines from the International Society for Traumatic Stress Studies, 2nd edn. New York: Guilford Press, 2009.
45. BC Provincial Mental Health and Substance Use Planning Council. Trauma informed practice guide. Accessed at: http://bccewhbcca/wp-content/uploads/2012/05/2013_TIP-Guide.pdf (accessed September 2015), 2013.
46. Najavits LM, Ryngala D, Back SE, et al. Comorbid disorders. In: Foa EB, Keane TM, Friedman MJ, Cohen JA, eds eds. Effective treatments for PTSD: practice guidelines from the International Society for Traumatic Stress Studies, 2nd edn. New York, NY: Guilford, 2009:508–35.
47. Haskell L. First stage trauma treatment: a guide for mental health professionals working with women. Ontario: Centre for Addiction and Mental Health, 2003.
48. Briggs CL. Theorizing modernity conspiratorially: science, scale, and the political economy of public discourse in explanations of a cholera epidemic. Am Ethnol 2004;31:164–87.